PE78999A1 - 2-amino-7-(2-hidroxietilo 1-sustituido)-3,5-dihidropirrolo [3,2-d] pirimidin-4 onas - Google Patents

2-amino-7-(2-hidroxietilo 1-sustituido)-3,5-dihidropirrolo [3,2-d] pirimidin-4 onas

Info

Publication number
PE78999A1
PE78999A1 PE1998000424A PE00042498A PE78999A1 PE 78999 A1 PE78999 A1 PE 78999A1 PE 1998000424 A PE1998000424 A PE 1998000424A PE 00042498 A PE00042498 A PE 00042498A PE 78999 A1 PE78999 A1 PE 78999A1
Authority
PE
Peru
Prior art keywords
compound
dihydropyrolle
pirimidin
onas
hydroxyethyl
Prior art date
Application number
PE1998000424A
Other languages
English (en)
Spanish (es)
Inventor
Duzer John Henry Van
Leslie Wighton Mcquire
Benjamin Biro Mugrage
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE78999A1 publication Critical patent/PE78999A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Transplantation (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
PE1998000424A 1997-05-29 1998-05-27 2-amino-7-(2-hidroxietilo 1-sustituido)-3,5-dihidropirrolo [3,2-d] pirimidin-4 onas PE78999A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4801897P 1997-05-29 1997-05-29

Publications (1)

Publication Number Publication Date
PE78999A1 true PE78999A1 (es) 1999-09-08

Family

ID=21952319

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998000424A PE78999A1 (es) 1997-05-29 1998-05-27 2-amino-7-(2-hidroxietilo 1-sustituido)-3,5-dihidropirrolo [3,2-d] pirimidin-4 onas

Country Status (13)

Country Link
US (1) US6043365A (xx)
EP (1) EP0986563A1 (xx)
JP (1) JP2002500658A (xx)
CN (1) CN1107068C (xx)
AR (1) AR012871A1 (xx)
AU (1) AU8210798A (xx)
BR (1) BR9809178A (xx)
CA (1) CA2288317A1 (xx)
CO (1) CO4940437A1 (xx)
PE (1) PE78999A1 (xx)
TW (1) TW509692B (xx)
WO (1) WO1998054185A1 (xx)
ZA (1) ZA984561B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6946554B2 (en) * 1996-12-10 2005-09-20 Biocryst Pharmaceuticals, Inc. Process for the preparation of 9-deazaguanine derivatives
WO2006086498A2 (en) * 2005-02-08 2006-08-17 Aspreva Pharmaceuticals Sa Treatment of vascular, autoimmune and inflammatory diseases using low dosages of impdh inhibitors
NZ593648A (en) 2008-12-23 2013-09-27 Gilead Pharmasset Llc Nucleoside phosphoramidates
CL2009002206A1 (es) 2008-12-23 2011-08-26 Gilead Pharmasset Llc Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales.
EP2376514A2 (en) 2008-12-23 2011-10-19 Pharmasset, Inc. Nucleoside analogs
WO2010111381A2 (en) * 2009-03-24 2010-09-30 Biocryst Pharmaceuticals, Inc. Useful pharmaceutical salts of 7-[(3r, 4r)-3-hydroxy-4-hydroxymethyl-pyrrolidin-1-ylmethyl]-3,5-dihydro-pyrrolo[3,2-d]pyrimidin-4-one
KR101715981B1 (ko) 2010-03-31 2017-03-13 길리애드 파마셋 엘엘씨 뉴클레오사이드 포스포르아미데이트

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923872A (en) * 1986-08-26 1990-05-08 Warner-Lambert Co. Analogues of pyrrolo[3,2d]pyrimidin-4-ones
JP2760364B2 (ja) * 1989-02-27 1998-05-28 バイオクライシス・ファーマシューティカルズ、インコーポレイテッド ９―置換―８―非置換―９―デアザグアニン類
CA2072123C (en) * 1989-10-31 2001-06-12 John A. Secrist, Iii Inhibitors of purine nucleoside phosphorylase
US5189039A (en) * 1989-11-29 1993-02-23 Biocryst, Inc. 7-disubstituted-methyl-4-oxo-3H,5H-pyrrolo[3,2d]pyrimidine and pharmaceutical uses and compositions containing the same
US5726311A (en) * 1989-11-29 1998-03-10 Biocryst Pharmaceuticals, Inc. 7-disubstituted-methyl-4-oxo-3H,5H-pyrrolo 3,2-d!pyrimidine and pharmaceutical uses and compositions containing the same
RU94046387A (ru) * 1992-04-21 1996-09-27 Биокрист Фармасьютикалз Производные пиримидина, способ их получения, фармацевтическая композиция, ее применение и промежуточные продукты

Also Published As

Publication number Publication date
JP2002500658A (ja) 2002-01-08
CN1257503A (zh) 2000-06-21
AR012871A1 (es) 2000-11-22
CN1107068C (zh) 2003-04-30
BR9809178A (pt) 2000-08-01
US6043365A (en) 2000-03-28
EP0986563A1 (en) 2000-03-22
TW509692B (en) 2002-11-11
CO4940437A1 (es) 2000-07-24
CA2288317A1 (en) 1998-12-03
AU8210798A (en) 1998-12-30
ZA984561B (en) 1998-11-30
WO1998054185A1 (en) 1998-12-03

Similar Documents

Publication Publication Date Title
ATE206466T1 (de) Vermittler, geeignet für die elektrochemische regenerierung von nadh, nadph oder deren analoga
PE78999A1 (es) 2-amino-7-(2-hidroxietilo 1-sustituido)-3,5-dihidropirrolo [3,2-d] pirimidin-4 onas
HK1036622A1 (en) Fused pyrrolocarbazoles.
DK724088D0 (da) Purinyl- pyrimidinylcyclobutaner
MY102693A (en) Antiviral nucleosides
ITMI931396A1 (it) Analoghi eterociclici di 1, 2, 4-triazolo(15-c)pirimidine ad attivita' antagonista per il recettore a2 dell'adenosina
BR9912951A (pt) Método de fabricação de nucleotìdoes de 1,3-oxatiolano
ATE132752T1 (de) Antivirale zusammensetzung
NO179953C (no) Kvantitativ metode for bestemmelse av 1,4-dihydronikotinamid-adenin-dinukleotid i opplösning, samt engangs enzymelektrode
EP1165560A4 (en) 2-HYDROXY METHYLCYCLOPRO PYLIDENEMETHYL PURINES AND PYRIMIDINES AS ANTIVIRAL AGENTS
AU2410988A (en) Diagnostic probe for diabetes type i predisposition
KR900016249A (ko) 항바이러스제 3'-치환 메틸 뉴클레오사이드류
AR246082A1 (es) Triazolinonas substituidas.
HK1034512A1 (en) Process for the production of purine derivatives and intermediates therefor
NO970716L (no) Sekvens-spesifikke bindingsoligomerer for nukleinsyrer og deres anvendelse i antisense-strategier
Barry Chemoenzymatic synthesis of analogues of the second messenger candidate cyclic adenosine 5′-diphosphate ribose
GB1021962A (en) Process for preparing 5-nucleotides
ATE98249T1 (de) Phosphonoalkylpurin-derivate.
WO2003104440A3 (en) PURINES OR PYRIMIDINES 2,2-BIS- (HYDROXYMETHYL) CYCLOPROPYLIDENEMETHYLE USED AS ANTIVIRAL AGENTS
JPS6422853A (en) Nucleoside analog
HK1009451A1 (en) Process for the synthesis of nucleoside analogues
Kawashima Studies on Nucleic Acid Antagonists. IV. Inhibitory Effect of 5-Phenylazopyrimidines on the Enzymatic Conversion of Folic Acid to Citrovorum Factor in vitro.
GEP20002030B (en) Diastereoselective Synthesis of Nucleosides
JPS53115891A (en) Preparation of nicotinic amide.adenine.dinucleotide.phosphate
RU97108066A (ru) Производные нуклеозидов и способ их получения

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed